Xanthenylacetic Acid Derivatives Effectively Target Lysophosphatidic Acid Receptor 6 to Inhibit Hepatocellular Carcinoma Cell Growth-Reference-Cited by-同舟云学术

Xanthenylacetic Acid Derivatives Effectively Target Lysophosphatidic Acid Receptor 6 to Inhibit Hepatocellular Carcinoma Cell Growth

Published:2021-06-02 Issue: Volume: Page:
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Gnocchi Davide¹,Cavalluzzi Maria M.²,Mangiatordi Giuseppe F.³,Rizzi Rosanna³,Tortorella Cosimo¹,Spennacchio Mauro²³,Lentini Giovanni²,Altomare Angela³,Sabbà Carlo¹,Mazzocca Antonio¹^ORCID

Affiliation:

1. Interdisciplinary Department of Medicine University of Bari, School of Medicine Piazza G. Cesare, 11 70124 Bari Italy

2. Department of Pharmacy - Drug Sciences University of Bari Aldo Moro via Orabona, 4 70125 Bari Italy

3. Institute of Crystallography CNR Via Amendola 122/o 70126 Bari Italy

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cmdc.202100032

Reference37 articles.

1. Management of HCC

2. Systemic Therapy for Hepatocellular Carcinoma: Latest Advances

3. Recent developments with immunotherapy for hepatocellular carcinoma

4. Acute liver failure caused by pembrolizumab in a patient with pulmonary metastatic liver cancer

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. hERG stereoselective modulation by mexiletine‐derived ureas: Molecular docking study, synthesis, and biological evaluation;Archiv der Pharmazie;2023-07-17

2. Lactic acid fermentation: A maladaptive mechanism and an evolutionary throwback boosting cancer drug resistance;Biochimie;2023-05

3. Metabolism as a New Avenue for Hepatocellular Carcinoma Therapy;International Journal of Molecular Sciences;2023-02-13

4. Inhibition of lysophosphatidic acid receptor 6 upregulated by the choline‐deficient l‐amino acid‐defined diet prevents hepatocarcinogenesis in mice;Molecular Carcinogenesis;2023-02-08

5. Inhibition of LPAR6 overcomes sorafenib resistance by switching glycolysis into oxidative phosphorylation in hepatocellular carcinoma;Biochimie;2022-11